Low molecular weight heparins prevent the induction of autophagy of activated neutrophils and the formation of neutrophil extracellular traps

Pharmacological Research

Volumn 123, Issue , 2017, Pages 146-156

  Manfredi, Angelo A ^a,b   Rovere Querini, Patrizia ^a,b   D'Angelo, Armando ^a   Maugeri, Norma ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Innate immunity; Low molecular weight heparins; Neutrophil extracellular traps; Neutrophils

Indexed keywords

3 METHYLADENINE; ENOXAPARIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 8; MYELOPEROXIDASE; PARNAPARIN; PHORBOL 13 ACETATE 12 MYRISTATE; RAPAMYCIN; WORTMANNIN; ANTIINFLAMMATORY AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOPHAGY; BYSTANDER EFFECT; CELL LINE; CONFOCAL MICROSCOPY; ELECTRON MICROSCOPY; EXTRACELLULAR TRAP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE ACTIVATION; NEUTROPHIL GRANULE; NORMAL HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; DRUG EFFECT; NEUTROPHIL;

ANTI-INFLAMMATORY AGENTS; AUTOPHAGY; EXTRACELLULAR TRAPS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; NEUTROPHILS;

EID: 85011578539     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2016.08.008     Document Type: Article

References (87)

1. McDonald, B., Urrutia, R., Yipp, B.G., Jenne, C.N., Kubes, P., Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe 12 (2012), 324–333.
2. Bardoel, B.W., Kenny, E.F., Sollberger, G., Zychlinsky, A., The balancing act of neutrophils. Cell Host Microbe 15 (2014), 526–536.
3. Sorensenand, O.E., Borregaard, N., Neutrophil extracellular traps – the dark side of neutrophils. J. Clin. Invest. 126 (2016), 1612–1620.
4. Clark, S.R., Ma, A.C., Tavener, S.A., McDonald, B., Goodarzi, Z., Kelly, M.M., Patel, K.D., Chakrabarti, S., McAvoy, E., Sinclair, G.D., Keys, E.M., Allen-Vercoe, E., Devinney, R., Doig, C.J., Green, F.H., Kubes, P., Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13 (2007), 463–469.
5. Yippand, B.G., Kubes, P., NETosis: how vital is it?. Blood 122 (2013), 2784–2794.
6. Manfredi, A.A., Covino, C., Rovere-Querini, P., Maugeri, N., Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. Clin. Exp. Immunol. 179 (2015), 24–29.
7. Neeli, I., Khan, S.N., Radic, M., Histone deimination as a response to inflammatory stimuli in neutrophils. J. Immunol. 180 (2008), 1895–1902.
8. Leshner, M., Wang, S., Lewis, C., Zheng, H., Chen, X.A., Santy, L., Wang, Y., PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front. Immunol., 3, 2012, 307.
9. Papayannopoulos, V., Metzler, K.D., Hakkim, A., Zychlinsky, A., Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191 (2010), 677–691.
10. Remijsen, Q., Vanden Berghe, T., Wirawan, E., Asselbergh, B., Parthoens, E., De Rycke, R., Noppen, S., Delforge, M., Willems, J., Vandenabeele, P., Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res. 21 (2011), 290–304.
11. Mitroulis, I., Kambas, K., Chrysanthopoulou, A., Skendros, P., Apostolidou, E., Kourtzelis, I., Drosos, G.I., Boumpas, D.T., Ritis, K., Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout. PLoS One, 6, 2011, e29318.
12. Maugeri, N., Campana, L., Gavina, M., Covino, C., De Metrio, M., Panciroli, C., Maiuri, L., Maseri, A., D'Angelo, A., Bianchi, M.E., Rovere-Querini, P., Manfredi, A.A., Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J. Thrombosis Haemostasis: JTH 12 (2014), 2074–2088.
13. Chrysanthopoulou, A., Mitroulis, I., Apostolidou, E., Arelaki, S., Mikroulis, D., Konstantinidis, T., Sivridis, E., Koffa, M., Giatromanolaki, A., Boumpas, D.T., Ritis, K., Kambas, K., Neutrophil extracellular traps promote differentiation and function of fibroblasts. J. Pathol. 233 (2014), 294–307.
14. Tang, S., Zhang, Y., Yin, S.W., Gao, X.J., Shi, W.W., Wang, Y., Huang, X., Wang, L., Zou, L.Y., Zhao, J.H., Huang, Y.J., Shan, L.Y., Gounni, A.S., Wu, Y.Z., Zhang, J.B., Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis. Clin. Exp. Immunol. 180 (2015), 408–418.
15. Radicand, M., Marion, T.N., Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin. Immunopathol. 35 (2013), 465–480.
16. Guptaand, S., Kaplan, M.J., The role of neutrophils and NETosis in autoimmune and renal diseases. Nat. Rev. Nephrol. 12 (2016), 402–413.
17. von Bruhl, M.L., Stark, K., Steinhart, A., Chandraratne, S., Konrad, I., Lorenz, M., Khandoga, A., Tirniceriu, A., Coletti, R., Kollnberger, M., Byrne, R.A., Laitinen, I., Walch, A., Brill, A., Pfeiler, S., Manukyan, D., Braun, S., Lange, P., Riegger, J., Ware, J., Eckart, A., Haidari, S., Rudelius, M., Schulz, C., Echtler, K., Brinkmann, V., Schwaiger, M., Preissner, K.T., Wagner, D.D., Mackman, N., Engelmann, B., Massberg, S., Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209 (2012), 819–883.
18. Caudrillier, A., Kessenbrock, K., Gilliss, B.M., Nguyen, J.X., Marques, M.B., Monestier, M., Toy, P., Werb, Z., Looney, M.R., Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J. Clin. Invest. 122 (2012), 2661–2671.
19. Martinodand, K., Wagner, D.D., Thrombosis: tangled up in NETs. Blood 123 (2014), 2768–2776.
20. Maugeri, N., Rovere-Querini, P., Baldini, M., Baldissera, E., Sabbadini, M.G., Bianchi, M.E., Manfredi, A.A., Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid. Redox Signal. 20 (2014), 1060–1074.
21. Fuchs, T.A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D.D. Jr., Wrobleski, S.K., Wakefield, T.W., Hartwig, J.H., Wagner, D.D., Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 15880–15885.
22. Pfeiler, S., Massberg, S., Engelmann, B., Biological basis and pathological relevance of microvascular thrombosis. Thromb. Res. 133:Suppl. 1 (2014), S35–S37.
23. Leppkes, M., Maueroder, C., Hirth, S., Nowecki, S., Gunther, C., Billmeier, U., Paulus, S., Biermann, M., Munoz, L.E., Hoffmann, M., Wildner, D., Croxford, A.L., Waisman, A., Mowen, K., Jenne, D.E., Krenn, V., Mayerle, J., Lerch, M.M., Schett, G., Wirtz, S., Neurath, M.F., Herrmann, M., Becker, C., Externalized decondensed neutrophil chromatin occludes pancreatic ducts and drives pancreatitis. Nat. Commun., 7, 2016, 10973.
24. Wright, T.K., Gibson, P.G., Simpson, J.L., McDonald, V.M., Wood, L.G., Baines, K.J., Neutrophil extracellular traps are associated with inflammation in chronic airway disease. Respirology 21 (2016), 467–475.
25. Apostolidou, E., Skendros, P., Kambas, K., Mitroulis, I., Konstantinidis, T., Chrysanthopoulou, A., Nakos, K., Tsironidou, V., Koffa, M., Boumpas, D.T., Ritis, K., Neutrophil extracellular traps regulate IL-1beta-mediated inflammation in familial Mediterranean fever. Ann. Rheumat. Dis. 75 (2016), 269–277.
26. Barnado, A., Crofford, L.J., Oates, J.C., At the bedside: neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J. Leukocyte Biol. 99 (2016), 265–278.
27. Ramirez, G.A., Maugeri, N., Sabbadini, M.G., Rovere-Querini, P., Manfredi, A.A., Intravascular immunity as a key to systemic vasculitis: a work in progress gaining momentum. Clin. Exp. Immunol. 175 (2014), 150–166.
28. Maugeri, N., Rovere-Querini, P., Manfredi, A.A., Disruption of a regulatory network consisting of neutrophils and platelets fosters persisting inflammation in rheumatic diseases. Front. Immunol., 7, 2016, 182.
29. Schauer, C., Janko, C., Munoz, L.E., Zhao, Y., Kienhofer, D., Frey, B., Lell, M., Manger, B., Rech, J., Naschberger, E., Holmdahl, R., Krenn, V., Harrer, T., Jeremic, I., Bilyy, R., Schett, G., Hoffmann, M., Herrmann, M., Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 20 (2014), 511–517.
30. Lewis, H.D., Liddle, J., Coote, J.E., Atkinson, S.J., Barker, M.D., Bax, B.D., Bicker, K.L., Bingham, R.P., Campbell, M., Chen, Y.H., Chung, C.W., Craggs, P.D., Davis, R.P., Eberhard, D., Joberty, G., Lind, K.E., Locke, K., Maller, C., Martinod, K., Patten, C., Polyakova, O., Rise, C.E., Rudiger, M., Sheppard, R.J., Slade, D.J., Thomas, P., Thorpe, J., Yao, G., Drewes, G., Wagner, D.D., Thompson, P.R., Prinjha, R.K., Wilson, D.M., Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat. Chem. Biol. 11 (2015), 189–191.
31. Totani, L., Amore, C., Di Santo, A., Dell'Elba, G., Piccoli, A., Martelli, N., Tenor, H., Beume, R., Evangelista, V., Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes. J. Thromb. Haemost. 14 (2016), 191–204.
32. Tarantino, E., Amadio, P., Squellerio, I., Porro, B., Sandrini, L., Turnu, L., Cavalca, V., Tremoli, E., Barbieri, S.S., Role of thromboxane-dependent platelet activation in venous thrombosis: aspirin effects in mouse model. Pharmacol. Res. 107 (2016), 415–425.
33. Longstaff, C., Hogwood, J., Gray, E., Komorowicz, E., Varju, I., Varga, Z., Kolev, K., Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. Thromb. Haemost. 115 (2016), 591–599.
34. Mulloy, B., Hogwood, J., Gray, E., Lever, R., Page, C.P., Pharmacology of heparin and related drugs. Pharmacol. Rev. 68 (2016), 76–141.
35. Koenig, A., Norgard-Sumnicht, K., Linhardt, R., Varki, A., Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J. Clin. Invest. 101 (1998), 877–889.
36. Varkiand, A., Varki, N.M., P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications. Braz. J. Med. Biol. Res. Revista brasileira de pesquisas medicas e biologicas/Sociedade Brasileira de Biofisica [et al]. 34 (2001), 711–717.
37. Borsig, L., Wong, R., Feramisco, J., Nadeau, D.R., Varki, N.M., Varki, A., Heparin and cancer revisited: mechanistic connections involving platelets P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 3352–3357.
38. Borsig, L., Wong, R., Hynes, R.O., Varki, N.M., Varki, A., Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 2193–2198.
39. Matsui, N.M., Varki, A., Embury, S.H., Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin. Blood 100 (2002), 3790–3796.
40. Wang, L., Brown, J.R., Varki, A., Esko, J.D., Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J. Clin. Invest. 110 (2002), 127–136.
41. Wahrenbrock, M., Borsig, L., Le, D., Varki, N., Varki, A., Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J. Clin. Invest. 112 (2003), 853–862.
42. Maugeri, N., de Gaetano, G., Barbanti, M., Donati, M.B., Cerletti, C., Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin. Haematologica 90 (2005), 833–839.
43. Maugeri, N., Di Fabio, G., Barbanti, M., de Gaetano, G., Donati, M.B., Cerletti Parnaparin, C., a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood. Thromb. Haemost. 97 (2007), 965–973.
44. Maugeriand, N., Manfredi, A.A., Tissue factor expressed by neutrophils: another piece in the vascular inflammation puzzle. Sem. Thromb. Hemost. 41 (2015), 728–736.
45. Marder, W., Knight, J.S., Kaplan, M.J., Somers, E.C., Zhang, X., O'Dell, A.A., Padmanabhan, V., Lieberman, R.W., Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies. Lupus Sci. Med., 3, 2016, e000134.
46. He, Z., Si, Y., Jiang, T., Ma, R., Zhang, Y., Cao, M., Li, T., Yao, Z., Zhao, L., Fang, S., Yu, B., Dong, Z., Thatte, H.S., Bi, Y., Kou, J., Yang, S., Piao, D., Hao, L., Zhou, J., Shi, J., Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thromb. Haemost. 115 (2016), 738–751.
47. Wang, A., Ren, J., Wang, C.P., Hascall, V.C., Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division. J. Biol. Chem. 289 (2014), 9418–9942.
48. Wang, A., Sankaranarayanan, N.V., Yanagishita, M., Templeton, D.M., Desai, U.R., Sugahara, K., Wang, C.P., Hascall, V.C., Heparin interaction with a receptor on hyperglycemic dividing cells prevents intracellular hyaluronan synthesis and autophagy responses in models of type 1 diabetes. Matrix Biol. 48 (2015), 36–41.
49. Maugeri, N., Rovere-Querini, P., Evangelista, V., Covino, C., Capobianco, A., Bertilaccio, M.T., Piccoli, A., Totani, L., Cianflone, D., Maseri, A., Manfredi, A.A., Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood 113 (2009), 5254–5265.
50. Manfredi, A.A., Baldini, M., Camera, M., Baldissera, E., Brambilla, M., Peretti, G., Maseri, A., Rovere-Querini, P., Tremoli, E., Sabbadini, M.G., Maugeri, N., Anti-TNFalpha agents curb platelet activation in patients with rheumatoid arthritis. Ann. Rheum. Dis. 75 (2016), 1511–1520.
51. Maugeri, N., Malato, S., Femia, E.A., Pugliano, M., Campana, L., Lunghi, F., Rovere-Querini, P., Lussana, F., Podda, G., Cattaneo, M., Ciceri, F., Manfredi, A.A., Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. Blood 118 (2011), 3359–3366.
52. Klionsky, D.J., Abdelmohsen, K., Abe, A., Abedin, M.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12 (2016), 1–222.
53. Brown, R.A., Lever, R., Jones, N.A., Page, C.P., Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro. Br. J. Pharmacol. 139 (2003), 845–853.
54. Lever, R., Lo, W.T., Faraidoun, M., Amin, V., Brown, R.A., Gallagher, J., Page, C.P., Size-fractionated heparins have differential effects on human neutrophil function in vitro. Br. J. Pharmacol. 151 (2007), 837–843.
55. Laghi Pasini, F., Pasqui, A.L., Ceccatelli, L., Capecchi, P.L., Orrico, A., Di Perri, T., Heparin inhibition of polymorphonuclear leukocyte activation in vitro: a possible pharmacological approach to granulocyte-mediated vascular damage. Thromb. Res. 35 (1984), 527–553.
56. Freischlag, J.A., Colburn, M.D., Quinones-Baldrich, W.J., Moore, W.S., Alteration of neutrophil (PMN) function by heparin, dexamethasone, and enalapril. J. Surg. Res. 52 (1992), 523–552.
57. Bazzoni, G., Beltran Nunez, A., Mascellani, G., Bianchini, P., Dejana, E., Del Maschio, A., Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J. Lab. Clin. Med. 121 (1993), 268–275.
58. Piccardoni, P., Evangelista, V., Piccoli, A., de Gaetano, G., Walz, A., Cerletti, C., Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes. Thromb. Haemost. 76 (1996), 780–785.
59. Manfredi, A.A., Rovere-Querini, P., Maugeri, N., Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr. Opin. Hematol. 17 (2010), 3–8.
60. Brown, R.A., Leung, E., Kankaanranta, H., Moilanen, E., Page, C.P., Effects of heparin and related drugs on neutrophil function. Pulm. Pharmacol. Ther. 25 (2012), 185–192.
61. Ahmed, T., Garrigo, J., Danta, I., Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. N. Engl. J. Med. 329 (1993), 90–99.
62. Bowler, S.D., Smith, S.M., Lavercombe, P.S., Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am. Rev. Respir. Dis. 147 (1993), 160–163.
63. Diamant, Z., Timmers, M.C., van der Veen, H., Page, C.P., van der Meer, F.J., Sterk, P.J., Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Am. J. Respir. Crit. Care Med. 153 (1996), 1790–1795.
64. Brown, R.A., Allegra, L., Matera, M.G., Page, C.P., Cazzola, M., Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination. Pulm. Pharmacol. Ther. 19 (2006), 419–424.
65. Gaffney, P.R., O'Leary, J.J., Doyle, C.T., Gaffney, A., Hogan, J., Smew, F., Annis, P., Response to heparin in patients with ulcerative colitis. Lancet 337 (1991), 238–239.
66. Gaffney, P.R., Doyle, C.T., Gaffney, A., Hogan, J., Hayes, D.P., Annis, P., Paradoxical response to heparin in 10 patients with ulcerative colitis. Am. J. Gastroenterol. 90 (1995), 220–223.
67. Evans, R.C., Wong, V.S., Morris, A.I., Rhodes, J.M., Treatment of corticosteroid-resistant ulcerative colitis with heparin – a report of 16 cases. Aliment Pharmacol. Ther. 11 (1997), 1037–1040.
68. Michell, N.P., Lalor, P., Langman, M.J., Heparin therapy for ulcerative colitis? Effects and mechanisms. Eur. J. Gastroenterol. Hepatol. 13 (2001), 449–456.
69. Ruffatti, A., Tonello, M., Visentin, M.S., Bontadi, A., Hoxha, A., De Carolis, S., Botta, A., Salvi, S., Nuzzo, M., Rovere-Querini, P., Canti, V., Mosca, M., Mitic, G., Bertero, M.T., Pengo, V., Boffa, M.C., Tincani, A., Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology 50 (2011), 1684–1689.
70. Dodd, J.M., McLeod, A., Windrim, R.C., Kingdom, J., Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst. Rev., 2013, CD006780.
71. McLaughlin, K., Drewlo, S., Parker, J.D., Kingdom, J.C., Current theories on the prevention of severe preeclampsia with low-molecular weight heparin. Hypertension 66 (2015), 1098–1103.
72. Tong, M., Viall, C.A., Chamley, L.W., Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment. Hum. Reprod. Update 21 (2015), 97–118.
73. Giaglis, S., Stoikou, M., Grimolizzi, F., Subramanian, B.Y., van Breda, S.V., Hoesli, I., Lapaire, O., Hasler, P., Than, N.G., Hahn, S., Neutrophil migration into the placenta: good, bad or deadly?. Cell Adhes. Migr. 10 (2016), 208–225.
74. Leffler, J., Stojanovich, L., Shoenfeld, Y., Bogdanovic, G., Hesselstrand, R., Blom, A.M., Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome. Clin. Exp. Rheumatol. 32 (2014), 66–70.
75. Yalavarthi, S., Gould, T.J., Rao, A.N., Mazza, L.F., Morris, A.E., Nunez-Alvarez, C., Hernandez-Ramirez, D., Bockenstedt, P.L., Liaw, P.C., Cabral, A.R., Knight, J.S., Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 67 (2015), 2990–3003.
76. Gupta, A.K., Hasler, P., Holzgreve, W., Gebhardt, S., Hahn, S., Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum. Immunol. 66 (2005), 1146–1154.
77. Saffarzadeh, M., Juenemann, C., Queisser, M.A., Lochnit, G., Barreto, G., Galuska, S.P., Lohmeyer, J., Preissner, K.T., Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One, 7, 2012, e32366.
78. Leffler, J., Martin, M., Gullstrand, B., Tyden, H., Lood, C., Truedsson, L., Bengtsson, A.A., Blom, A.M., Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol. 188 (2012), 3522–3531.
79. Wang, H., Wang, C., Zhao, M.H., Chen, M., Neutrophil extracellular traps can activate alternative complement pathways. Clin. Exp. Immunol. 181 (2015), 518–527.
80. Yuen, J., Pluthero, F.G., Douda, D.N., Riedl, M., Cherry, A., Ulanova, M., Kahr, W.H., Palaniyar, N., Licht, C., NETosing neutrophils activate complement both on their own NETs and bacteria via alternative and non-alternative pathways. Front. Immunol., 7, 2016, 137.
81. Schneider, A.E., Sandor, N., Karpati, E., Jozsi, M., Complement factor H modulates the activation of human neutrophil granulocytes and the generation of neutrophil extracellular traps. Mol. Immunol. 72 (2016), 37–48.
82. Ramirez, G.A., Rovere-Querini, P., Sabbadini, M.G., Manfredi, A.A., Parietal and intravascular innate mechanisms of vascular inflammation. Arthritis Res. Ther., 17, 2015, 16.
83. Boban, A., Paulus, S., Lambert, C., Hermans, C., The value and impact of anti-Xa activity monitoring for prophylactic dose adjustment of low-molecular-weight heparin during pregnancy: a retrospective study. Blood Coagul. Fibrinolysis(June 2), 2016, 10.1097/MBC.0000000000000573 [Epub ahead of print].
84. Whiteand, R.H., Ginsberg, J.S., Low-molecular-weight heparins: are they all the same?. Br. J. Haematol. 121 (2003), 12–20.
85. Canti, V., Castiglioni, M.T., Rosa, S., Franchini, S., Sabbadini, M.G., Manfredi, A.A., Rovere-Querini, P., Pregnancy outcomes in patients with systemic autoimmunity. Autoimmunity 45 (2012), 169–175.
86. Canti, V., Maggio, L., Ramirez, G.A., Locatelli, A., Cozzolino, S., Ramoni, V., Ruffatti, A., Tonello, M., Valsecchi, L., Rosa, S., Inversetti, A., Manfredi, A.A., Sabbadini, M.G., Castiglioni, M.T., Rovere-Querini, P., Hypertension negatively affects the pregnancy outcome in patients with antiphospholipid syndrome. Lupus 21 (2012), 810–812.
87. Alijotas-Reig, J., Ferrer-Oliveras, R., Ruffatti, A., Tincani, A., Lefkou, E., Bertero, M.T., Coloma-Bazan, E., de Carolis, S., Espinosa, G., Rovere-Querini, P., Kuzenko, A., Valverde, E.E., Robles, A., Cervera, R., Canti, V., Fredi, M., Gil-Aguado, A., Lundelin, K., Llurba, E., Melnychuk, T., Nalli, C., Picardo, E., Silvestro, E., del Ross, T., Farran-Codina, I., The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a survey of 247 consecutive cases. Autoimmun. Rev. 14 (2015), 387–395.